An interventional study of 4-7-8 Breathing Exercise in Type 2 Diabetes Mellitus (DM), sponsored by Artvin Coruh University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Artvin Coruh University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This randomized controlled trial aims to evaluate the effects of 4-7-8 breathing exercises on perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus.
The study will be conducted at the Internal Medicine Outpatient Clinic of Kayseri City Hospital, Türkiye. A total of 60 patients aged 18-65 years who have been newly diagnosed with type 2 diabetes mellitus and have HbA1c levels of 8% or higher will be enrolled. Participants will be randomly assigned to either the intervention group (n=30) or the control group (n=30) using simple randomization.
Participants in the intervention group will perform 4-7-8 breathing exercises twice daily, in the morning and evening, for four weeks, in addition to receiving routine diabetes treatment. The breathing technique involves inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling through the mouth for 8 seconds. Participants will be instructed to perform four sets per session. Participants in the control group will continue receiving routine diabetes treatment without any additional breathing exercises.
Data will be collected at baseline and at the end of the four-week intervention using the Perceived Stress Scale (PSS-14), the World Health Organization-Five Well-Being Index (WHO-5), and the Short Form-36 Health Survey (SF-36).
The study will investigate whether 4-7-8 breathing exercises improve perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus compared with routine care alone.
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that requires continuous treatment, lifestyle modifications, and self-management. Receiving a new diagnosis of T2DM may lead to psychological distress, uncertainty, and difficulties adapting to disease-related responsibilities. These challenges may negatively affect perceived stress, mental well-being, and quality of life during the early stages of disease management.
Controlled breathing exercises are non-pharmacological interventions that may help regulate physiological and psychological responses to stress. The 4-7-8 breathing technique involves a structured breathing pattern designed to promote relaxation through controlled inhalation, breath-holding, and prolonged exhalation. Although previous studies have investigated various breathing techniques in individuals with T2DM, evidence regarding the effects of 4-7-8 breathing exercises specifically in newly diagnosed patients remains limited.
This study is designed as a two-arm, parallel-group randomized controlled trial to investigate the effectiveness of 4-7-8 breathing exercises as a complementary intervention alongside routine diabetes treatment.
Following eligibility assessment and informed consent, participants will complete baseline assessments and be randomly allocated to the intervention or control group. Participants assigned to the intervention group will receive instructions on performing the 4-7-8 breathing technique and will practice the exercises twice daily for four weeks. Participants in both groups will continue their routine diabetes treatment throughout the study.
The study will assess three patient-reported outcomes: perceived stress, mental well-being, and health-related quality of life. Perceived stress will be evaluated using the 14-item Perceived Stress Scale (PSS-14), with higher scores indicating greater perceived stress. Mental well-being will be assessed using the WHO-5 Well-Being Index, with higher scores indicating better well-being. Health-related quality of life will be measured using the SF-36 Health Survey, which evaluates eight dimensions of physical and mental health.
Outcome assessments will be conducted at baseline and after the four-week intervention. The collected data will be analyzed using appropriate statistical methods to examine changes within groups and differences between groups.
The findings are expected to contribute to the evidence regarding the potential role of 4-7-8 breathing exercises as a simple, accessible, and non-pharmacological supportive intervention for patients newly diagnosed with T2DM.
10,386 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,411 are open to participants now.
This study's planned enrollment of 60 is below the median of 80 across 8,361 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →Artvin Coruh University is the lead sponsor of 30 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the experimental group will perform 4-7-8 breathing exercises twice daily (morning and evening), with four sets per session, for four weeks. Each breathing cycle consists of inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling slowly through the mouth for 8 seconds. Participants will continue receiving their routine diabetes treatment throughout the intervention period.
Behavioral: 4-7-8 Breathing Exercise
Participants in the control group will continue receiving routine diabetes treatment without performing 4-7-8 breathing exercises or receiving any additional breathing intervention during the four-week study period.
Participants in the intervention group will perform the 4-7-8 breathing exercise for four weeks in addition to their routine diabetes treatment. The technique consists of three consecutive steps: (1) exhaling completely through the mouth while making a whooshing sound; (2) closing the mouth, inhaling quietly through the nose for 4 seconds, and holding the breath for 7 seconds; and (3) exhaling slowly through the mouth for 8 seconds while making a whooshing sound. Participants will be instructed to perform the exercise twice daily, in the morning and evening, with four sets per session. Routine diabetes treatment will continue throughout the intervention period.
Change in Perceived Stress Scale (PSS-14) Score From Baseline to Week 4
Perceived stress will be assessed using the 14-item Perceived Stress Scale (PSS-14). Each item is rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). Total scores range from 0 to 56, with higher scores indicating greater perceived stress. The outcome will be assessed as the change in total PSS-14 score from baseline to Week 4. A decrease in the total score indicates a reduction in perceived stress.
Time frame: Baseline, Week 4
Change in WHO-5 Well-Being Index Score From Baseline to Week 4
Mental well-being will be assessed using the World Health Organization-Five Well-Being Index (WHO-5). The instrument consists of five items, each scored from 0 (at no time) to 5 (all of the time). The raw total score ranges from 0 to 25, with higher scores indicating better mental well-being. The outcome will be assessed as the change in the raw total WHO-5 score from baseline to Week 4. An increase in the score indicates improved mental well-being.
Time frame: Baseline, Week 4
Secondary Outcome 2 - Quality of Life (SF-36)
Health-related quality of life will be assessed using the 36-Item Short Form Health Survey (SF-36). The instrument consists of 36 items evaluating eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored separately from 0 to 100, with higher scores indicating better health-related quality of life. Changes in the eight domain scores from baseline to Week 4 will be evaluated. The SF-36 does not provide a single overall total score.
Time frame: Baseline, Week 4
No study locations are listed for this record.
Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.
Of 2,068 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 12 months is below that.
Counting every sponsor, half of 2,245 studies reached it within 21 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Artvin Coruh University